These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24447076)

  • 1. Identification and analysis of novel R308K mutation in glucokinase of type 2 diabetic patient and its kinetic correlation.
    Yellapu NK; Valasani KR; Pasupuleti SK; Gopal S; Potukuchi Venkata Gurunadha Krishna S; Matcha B
    Biotechnol Appl Biochem; 2014; 61(5):572-81. PubMed ID: 24447076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in exons 10 and 11 of human glucokinase result in conformational variations in the active site of the structure contributing to poor substrate binding - explains hyperglycemia in type 2 diabetic patients.
    Yellapu N; Mahto MK; Valasani KR; Sarma PV; Matcha B
    J Biomol Struct Dyn; 2015; 33(4):820-33. PubMed ID: 24720358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.
    Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T
    Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme.
    Liang Y; Kesavan P; Wang LQ; Niswender K; Tanizawa Y; Permutt MA; Magnuson MA; Matschinsky FM
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):167-73. PubMed ID: 7619052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucokinase in chicken (Gallus gallus). Partial cDNA cloning, immunodetection and activity determination.
    Berradi H; Taouis M; Cassy S; Rideau N
    Comp Biochem Physiol B Biochem Mol Biol; 2005 Jun; 141(2):129-39. PubMed ID: 15878833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing.
    García-Herrero CM; Rubio-Cabezas O; Azriel S; Gutierrez-Nogués A; Aragonés A; Vincent O; Campos-Barros A; Argente J; Navas MA
    PLoS One; 2012; 7(1):e30518. PubMed ID: 22291974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype.
    Miller SP; Anand GR; Karschnia EJ; Bell GI; LaPorte DC; Lange AJ
    Diabetes; 1999 Aug; 48(8):1645-51. PubMed ID: 10426385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of E339K mutated human glucokinase reveals changes in the ATP binding site.
    Liu Q; Shen Y; Liu S; Weng J; Liu J
    FEBS Lett; 2011 Apr; 585(8):1175-9. PubMed ID: 21420961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).
    Burke CV; Buettger CW; Davis EA; McClane SJ; Matschinsky FM; Raper SE
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):345-52. PubMed ID: 10455021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucokinase and glucose homeostasis: proven concepts and new ideas.
    Zelent D; Najafi H; Odili S; Buettger C; Weik-Collins H; Li C; Doliba N; Grimsby J; Matschinsky FM
    Biochem Soc Trans; 2005 Feb; 33(Pt 1):306-10. PubMed ID: 15667334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence.
    Zelent B; Odili S; Buettger C; Shiota C; Grimsby J; Taub R; Magnuson MA; Vanderkooi JM; Matschinsky FM
    Biochem J; 2008 Jul; 413(2):269-80. PubMed ID: 18370929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Variations of Human Glucokinase Glu256Lys in MODY2 Condition Using Molecular Dynamics Study.
    Yellapu NK; Kandlapalli K; Valasani KR; Sarma PV; Matcha B
    Biotechnol Res Int; 2013; 2013():264793. PubMed ID: 23476789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling and identification of novel glucokinase activators through stepwise virtual screening.
    Behera PM; Behera DK; Satpati S; Agnihotri G; Nayak S; Padhi P; Dixit A
    J Mol Graph Model; 2015 Apr; 57():122-30. PubMed ID: 25723349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes.
    Morral N; McEvoy R; Dong H; Meseck M; Altomonte J; Thung S; Woo SL
    Hum Gene Ther; 2002 Sep; 13(13):1561-70. PubMed ID: 12228011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type.
    Ralph EC; Sun S
    Biochemistry; 2009 Mar; 48(11):2514-21. PubMed ID: 19187021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
    Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
    Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.
    Chow E; Wang K; Lim CKP; Tsoi STF; Fan B; Poon E; Luk AOY; Ma RCW; Ferrannini E; Mari A; Chen L; Chan JCN
    Diabetes; 2023 Feb; 72(2):299-308. PubMed ID: 36342518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two MODY2 mutations with different susceptibility to activation.
    Langer S; Platz C; Waterstradt R; Baltrusch S
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1113-1119. PubMed ID: 26208450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis.
    Bourbonais FJ; Chen J; Huang C; Zhang Y; Pfefferkorn JA; Landro JA
    Biochem J; 2012 Feb; 441(3):881-7. PubMed ID: 22044397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.